Shaoyan Xi[Author] - Search Results

Year	Number of Results
2004	1
2012	2
2013	8
2014	5
2015	7
2016	8
2017	7
2018	4
2019	5
2020	10
2021	12
2022	8
2023	8
2024	4

1

Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN-null glioblastoma.

Ni X, Wu W, Sun X, Ma J, Yu Z, He X, Cheng J, Xu P, Liu H, Shang T, Xi S, Wang J, Zhang J, Chen Z. Ni X, et al. Among authors: xi s. Sci Adv. 2022 Jul 8;8(27):eabl5165. doi: 10.1126/sciadv.abl5165. Epub 2022 Jul 8. Sci Adv. 2022. PMID: 35857445 Free PMC article.

2

Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate.

Kong FE, Li GM, Tang YQ, Xi SY, Loong JHC, Li MM, Li HL, Cheng W, Zhu WJ, Mo JQ, Gong YF, Tang H, Zhao Y, Zhang Y, Ma S, Guan XY, Ma NF, Xie MB, Liu M. Kong FE, et al. Sci Transl Med. 2021 Feb 3;13(579):eabb6282. doi: 10.1126/scitranslmed.abb6282. Sci Transl Med. 2021. PMID: 33536280

3

Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study.

Chen G, Jin Y, Guan WL, Zhang RX, Xiao WW, Cai PQ, Liu M, Lin JZ, Wang FL, Li C, Quan TT, Xi SY, Zhang HZ, Pan ZZ, Wang F, Xu RH. Chen G, et al. Lancet Gastroenterol Hepatol. 2023 May;8(5):422-431. doi: 10.1016/S2468-1253(22)00439-3. Epub 2023 Mar 1. Lancet Gastroenterol Hepatol. 2023. PMID: 36870360 Clinical Trial.

4

Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.

Yuan SQ, Nie RC, Jin Y, Liang CC, Li YF, Jian R, Sun XW, Chen YB, Guan WL, Wang ZX, Qiu HB, Wang W, Chen S, Zhang DS, Ling YH, Xi SY, Cai MY, Huang CY, Yang QX, Liu ZM, Guan YX, Chen YM, Li JB, Tang XW, Peng JS, Zhou ZW, Xu RH, Wang F. Yuan SQ, et al. Nat Med. 2024 Feb;30(2):552-559. doi: 10.1038/s41591-023-02721-w. Epub 2024 Jan 2. Nat Med. 2024. PMID: 38167937 Clinical Trial.

5

Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma.

Cheng W, Li HL, Xi SY, Zhang XF, Zhu Y, Le Xing, Mo YX, Li MM, Kong FE, Zhu WJ, Chen XG, Cui HQ, Cao ZM, Gong YF, Tang YQ, Zhang Y, Guan XY, Ma NF, Liu M. Cheng W, et al. Nat Commun. 2021 Dec 8;12(1):7142. doi: 10.1038/s41467-021-27525-9. Nat Commun. 2021. PMID: 34880251 Free PMC article.

6

USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC.

Zheng J, Wu S, Tang M, Xi S, Wang Y, Ren J, Luo H, Hu P, Sun L, Du Y, Yang H, Wang F, Gao H, Dai Z, Ou X, Li Y. Zheng J, et al. Among authors: xi s. Cell Death Dis. 2023 Oct 11;14(10):670. doi: 10.1038/s41419-023-06210-3. Cell Death Dis. 2023. PMID: 37821439 Free PMC article.

7

UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma.

Wang Y, Hu P, Wang F, Xi S, Wu S, Sun L, Du Y, Zheng J, Yang H, Tang M, Gao H, Luo H, Lv Y, Yan J, Ou X, Li Y. Wang Y, et al. Among authors: xi s. Cell Death Dis. 2023 Jun 28;14(6):381. doi: 10.1038/s41419-023-05895-w. Cell Death Dis. 2023. PMID: 37380646 Free PMC article.

8

Radiomics-based survival risk stratification of glioblastoma is associated with different genome alteration.

Xu PF, Li C, Chen YS, Li DP, Xi SY, Chen FR, Li X, Chen ZP. Xu PF, et al. Comput Biol Med. 2023 Jun;159:106878. doi: 10.1016/j.compbiomed.2023.106878. Epub 2023 Apr 11. Comput Biol Med. 2023. PMID: 37060774

9

Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial.

Guo C, Yang Q, Xu P, Deng M, Jiang T, Cai L, Li J, Sai K, Xi S, Ouyang H, Liu M, Li X, Li Z, Ni X, Cao X, Li C, Wu S, Du X, Su J, Xue X, Wang Y, Li G, Qin Z, Yang H, Zhou T, Liu J, Hu X, Wang J, Jiang X, Lin F, Zhang X, Ke C, Lv X, Lv Y, Hu W, Zeng J, Chen Z, Zhong S, Wang H, Chen Y, Zhang J, Li D, Mou Y, Chen Z. Guo C, et al. Among authors: xi s. JAMA Netw Open. 2023 Jan 3;6(1):e2253285. doi: 10.1001/jamanetworkopen.2022.53285. JAMA Netw Open. 2023. PMID: 36705923 Free article. Clinical Trial.

10

Deep learning-derived spatial organization features on histology images predicts prognosis in colorectal liver metastasis patients after hepatectomy.

Qi L, Liang JY, Li ZW, Xi SY, Lai YN, Gao F, Zhang XR, Wang DS, Hu MT, Cao Y, Xu LJ, Chan RCK, Xing BC, Wang X, Li YH. Qi L, et al. iScience. 2023 Aug 23;26(10):107702. doi: 10.1016/j.isci.2023.107702. eCollection 2023 Oct 20. iScience. 2023. PMID: 37701575 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year